Globus Medical (GMED) Finished Goods (2018 - 2025)

Globus Medical has reported Finished Goods for 8 years, with the latest figure at $555.7 million in Q3 2025.

• For the quarter ending Q3 2025, Finished Goods changed 0.46% year-over-year to $555.7 million; the trailing twelve-month figure through Sep 2025 stood at $555.7 million (changed 0.46% YoY), and the FY2024 full-year result was $491.5 million, down 30.53% from the prior year.
• Finished Goods for Q3 2025 stood at $555.7 million, roughly flat from $558.4 million in the prior quarter.
• The five-year high for Finished Goods was $769.7 million in Q3 2023, with the low at $172.1 million in Q3 2021.
• Historically, Finished Goods has averaged $390.0 million across 5 years, with a median of $237.4 million in 2023.
• Annual changes were most pronounced in 2023 — Finished Goods jumped 273.12% — and 2024, when it tumbled 30.53%.
• Globus Medical's Finished Goods stood at $177.8 million in 2021, then gained by 23.72% to $220.0 million in 2022, then surged by 221.64% to $707.5 million in 2023, then plunged by 30.53% to $491.5 million in 2024, then gained by 13.08% to $555.7 million in 2025.
• The last three Finished Goods figures came in at $555.7 million (Q3 2025), $558.4 million (Q2 2025), and $497.0 million (Q1 2025), per Business Quant data.